The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in France to allow the sale of its consumer health branch to go ahead, Economy Minister Antoine Armand said on Monday. Sanofi said on Friday it had entered talks to sell a controlling 50% stake in its Opella business – whose brands include Doliprane – to US private equity firm Clayton Dubilier & Rice, but unions fear job cuts due to this.
#Doliprane #France #Sanofi
🔔 Subscribe to France 24 now: https://f24.my/YTen
🔴 LIVE – Watch FRANCE 24 English 24/7 here: https://f24.my/YTliveEN
🌍 Read the latest International News and Top Stories: https://www.france24.com/en/
Like us on Facebook: https://f24.my/FBen
Follow us on X (Twitter): https://f24.my/Xen
Browse the news in pictures on Instagram: https://f24.my/IGen
Discover our TikTok videos: https://f24.my/TKen
Get the latest top stories on Telegram: https://f24.my/TGen
